{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:59:29Z","timestamp":1790719169813,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.biologicals.2009.09.008","type":"journal-article","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T08:36:59Z","timestamp":1256891819000},"page":"260-264","source":"Crossref","is-referenced-by-count":8,"title":["Cloning, high level expression and immunogenicity of 1163-1256 residues of C-terminal heavy chain of C. botulinum neurotoxin type E"],"prefix":"10.1016","volume":"38","author":[{"given":"Abdoulreza Agheli","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Latif","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Rasooli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Amani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2009.09.008_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/15569549909036019","article-title":"Structure\u2013function relationship of clostridial neurotoxins","volume":"18","author":"Li","year":"1999","journal-title":"J\u00a0Toxicol Toxin Rev"},{"key":"10.1016\/j.biologicals.2009.09.008_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/77900","article-title":"Intimate details of the most poisonous poison","volume":"7","author":"Singh","year":"2000","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.biologicals.2009.09.008_bib3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1872-2075(07)60052-1","article-title":"High-level expression of the Hc domain of Clostridium botulinum neurotoxin serotype A in Escherichia coli and its immunogenicity as an antigen","volume":"3","author":"Yu","year":"2007","journal-title":"Chin J Biotechnol"},{"key":"10.1016\/j.biologicals.2009.09.008_bib4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.biologicals.2009.09.008_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4049\/jimmunol.90.5.697","article-title":"Studies on immunity to toxins of Clostridium botulinum. Ix. Immunologic response of man to purified pentavalent abcde botulinum toxiod","volume":"90","author":"Fiock","year":"1963","journal-title":"J Immunol"},{"key":"10.1016\/j.biologicals.2009.09.008_bib6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4049\/jimmunol.84.4.384","article-title":"Studies on immunity to toxins of Clostridium botulinum. V. Detoxification of purified type A and type B toxins, and the antigenicity of univalent and bivalent aluminium phosphate adsorbed toxoids","volume":"84","author":"Wright","year":"1960","journal-title":"J Immunol"},{"key":"10.1016\/j.biologicals.2009.09.008_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.toxicon.2006.02.013","article-title":"Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey","volume":"47","author":"Boles","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2009.09.008_bib8","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2009.09.008_bib9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0264-410X(96)00094-1","article-title":"Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum","volume":"14","author":"Dertzbaugh","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2009.09.008_bib10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0041-0101(95)00072-T","article-title":"Expression of a large, nontoxic fragment of botulinum neurotoxin serotype A and its use as an immunogen","volume":"33","author":"LaPenotiere","year":"1995","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2009.09.008_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1348-0421.2007.tb03919.x","article-title":"C terminal half fragment (50kDa) of heavy chain components of Clostridium botulinum type C and D neurotoxins can be used as an effective vaccine","volume":"51","author":"Lee","year":"2007","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.biologicals.2009.09.008_bib12","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.vaccine.2007.02.081","article-title":"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins","volume":"25","author":"Webb","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2009.09.008_bib13","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/IAI.73.10.6998-7005.2005","article-title":"Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E","volume":"73","author":"Baldwin","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2009.09.008_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/BF01886751","article-title":"Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species","volume":"15","author":"Atassi","year":"1996","journal-title":"J Protein Chem"},{"key":"10.1016\/j.biologicals.2009.09.008_bib15","first-page":"219","article-title":"Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins","volume":"19","author":"Atassi","year":"1999","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.biologicals.2009.09.008_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.biologicals.2009.09.008_bib17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0161-5890(97)00107-7","article-title":"Immune recognition of botulinum neurotoxin type A: regions recognized by T cells and antibodies against the protective H(C) fragment (residues 855-1296) of the toxin","volume":"34","author":"Oshima","year":"1997","journal-title":"Mol Immunol"},{"key":"10.1016\/j.biologicals.2009.09.008_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-2478(97)00124-7","article-title":"Antibodies and T cells against synthetic peptides of the C-terminal domain (Hc) of botulinum neurotoxin type A and their cross-reaction with Hc","volume":"60","author":"Oshima","year":"1998","journal-title":"Immunol Lett"},{"key":"10.1016\/j.biologicals.2009.09.008_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-2836(02)01403-1","article-title":"Two carbohydrate binding sites in the H (CC)-domain of tetanus neurotoxin are required for toxicity","volume":"326","author":"Rummel","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.biologicals.2009.09.008_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(99)00140-7","article-title":"Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice","volume":"1441","author":"Kitamura","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biologicals.2009.09.008_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/mpat.1998.0214","article-title":"Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins","volume":"25","author":"Kozaki","year":"1998","journal-title":"Microb Pathog"},{"key":"10.1016\/j.biologicals.2009.09.008_bib22","first-page":"215","article-title":"Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay","volume":"7","author":"Li","year":"1998","journal-title":"J Nat Toxins"},{"key":"10.1016\/j.biologicals.2009.09.008_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-5793(00)01954-2","article-title":"Structure-based sequence alignment for the beta-trefoil subdomain of the clostridial neurotoxin family provides residue level information about the putative ganglioside binding site","volume":"482","author":"Ginalski","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biologicals.2009.09.008_bib24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tim.2004.08.002","article-title":"Presynaptic receptor arrays for clostridial neurotoxins","volume":"12","author":"Montecucco","year":"2004","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.biologicals.2009.09.008_bib25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0300-9084(00)01169-X","article-title":"Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs","volume":"82","author":"Simpson","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.biologicals.2009.09.008_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.febslet.2004.06.094","article-title":"Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies","volume":"572","author":"Tavallaie","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biologicals.2009.09.008_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pep.2003.10.015","article-title":"Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain","volume":"34","author":"Zhou","year":"2004","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.biologicals.2009.09.008_bib28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1128\/AEM.63.4.1214-1218.1997","article-title":"Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies","volume":"63","author":"Kubota","year":"1997","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.biologicals.2009.09.008_bib29","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/nar\/19.7.1461","article-title":"Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA","volume":"19","author":"Romanos","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biologicals.2009.09.008_bib30","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1093\/nar\/17.24.10191","article-title":"Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons","volume":"17","author":"Makoff","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biologicals.2009.09.008_bib31","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/CVI.00239-08","article-title":"Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine","volume":"15","author":"Yu","year":"2008","journal-title":"Clin Vaccine Immunol"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105609001328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105609001328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T10:22:53Z","timestamp":1685182973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105609001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1045105609001328"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2009.09.008","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}